Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Clinical trial NCT00038493 · COMPLETED

Trial details

NCT number: NCT00038493
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2001-09-21
Primary completion: 2005-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.